INS and diabetes mellitus: The loss of β cell function is progressive throughout the course of diabetes, beginning with defect in first-phase insulin secretion, followed by a decreasing maximal capacity of insulin secretion, before a reduction of steady-state and basal insulin secretion and complete β cell failure requiring insulin treatment (45).